Ooni Koda
  1. Home
  2. /
  3. Newsfeed
  4. /
  5. Biofarm increases production of paracetamol-based syrups for children...

Biofarm increases production of paracetamol-based syrups for children due to increased market demand

January 5, 2023

Biofarm (stock symbol BIO), one of the most important drug manufacturers in Romania, announces increased production of paracetamol-based medicines for the treatment of fever and pain in children to meet increased market demand. We are in the middle of the children's respiratory season and paracetamol-based medicines are very hard to find or are missing from pharmacies. Therefore, we have mobilised and decided to significantly increase production of Bioflu Baby, a paracetamol-based syrup for treating fever and pain in children. Biofarm has an extensive portfolio of products for children colds and flu, and our two manufacturing facilities have the capacity to adapt quickly to any market need, said Catalin Vicol, Biofarm CEO.   Biofarm has always focused on aligning itself with market requirements and patient needs, being a company always oriented towards innovation and facilitating access to modern treatment solutions.   In the first ten months of 2022, Biofarm ranked 3rd in the Consumer Healthcare (CHC) segment in terms of number of units sold. The Cold Flu therapeutic area saw the highest growth in the Consumer Healthcare (CHC) category, with products such as Bioflu, Carmol, Bixtonim Xylo and Septosol recording double-digit growth.   Biofarm currently has two drug factories in Bucharest and a product testing and development unit, and its portfolio of over 200 products covers the most important therapeutic areas of the Consumer Healthcare division (digestive & metabolic, respiratory , ORL, cardiovascular ,circulatory, nervous system).   With more than 20 representative brands, Biofarm is the market leader in terms of volumes in the reference categories of nine of its brands: Colebil, Triferment, Carbocit, Sennalax, Bixtonim, Carmol, Biofen, Nervocalmin and Cavit.   About Biofarm   Biofarm® is one of the first Romanian drug and food supplements producers. For 100 years, Biofarm® has stood alongside Romanian specialists in the race to discover the best solutions for maintaining people health. Biofarm® is currently one of the top 10 existing producers on the pharmaceutical market in Romania, a very dynamic and competitive market. Biofarm® has a competitive product portfolio, covering 65 therapeutic areas, and is continuously investing in media, commercial and marketing campaigns to promote its products.      

Read in full - click here
Booking Holdings, Servier Pharma and JYSK lead 2025 Undelucram.ro ranking of top employers in Romania

Booking Holdings Romania, Servier Pharma, JYSK Romania, Schneider Electric, and Deichmann are the most appreciated companies by their own employees, according to Top Employers Undelucram.ro 2025. The list is based exclusively on feedback from employees rather than public image or marketing perception. The ranking made by Undelucram.ro, a leading online employee community in Romania, is […]

Romania’s new National Cathedral announces visiting schedule following 11-day pilgrimage

The Romanian Patriarchate announced the visiting schedule for the National Cathedral in Bucharest following the conclusion of an 11-day pilgrimage that drew hundreds of thousands of worshippers. Access for pilgrims to the Holy Altar is set to end at midnight on Wednesday, November 5, after continuous day-and-night visitation. According to the official announcement, the National […]

Prosecutors investigate doctors from the Republic of Moldova illegally practicing in Romania

Prosecutors and police officers in Romania conducted 14 searches on Wednesday, November 5, in a case concerning fraud, forgery of official documents, computer forgery, and unauthorized practice of a profession or activity. Specifically, prosecutors say several doctors from the Republic of Moldova who already practice in Romania did not actually complete their residency. Although they […]

Romania's purchasing power per capita 45% below EU average

Romania has reached a purchasing power per capita of EUR 11,105, approximately 45% below the European average – a figure that places the country in 31st place in the European top, according to the "NIQ Purchasing Power Europe 2025" study. Compared to 2024, Romania moved up one position in the NIQ ranking. Comparatively, at a […]

Former Eximbank head, finance minister freed in Romania under extraordinary prescription procedure

Ionuț Costea, former head of EximBank, and Sebastian Vlădescu, former finance minister, were released on November 5 following an extraordinary prescription procedure, according to a statement from Romania's High Court of Cassation and Justice (ICCJ). The two had been sentenced in 2023 to six and seven years in prison, respectively, for taking a EUR 5.5 […]

Romania's PM still expects to see key bills legislated in November

Prime minister Ilie Bolojan, who also serves as president of the Liberal Party (PNL), stated on November 4 that, at the meeting of the party's National Political Bureau the same day, support was renewed for resolving the issue related to special (magistrates') pensions this month, but also for the reform in public administration, according to